Moderna's mRNA vaccine cocktail passes early safety check

NCT ID NCT05397223

First seen Apr 02, 2026 · Last updated Jun 10, 2026 · Updated 8 times

Summary

This study tested the safety and immune response of several Moderna mRNA vaccines for COVID-19, seasonal flu, RSV, and CMV in 308 healthy adults aged 18 to 75. Researchers monitored side effects and measured antibody levels after vaccination. The goal was to ensure the vaccines are safe and trigger a strong immune response.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SARS-COV 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Benchmark Research

    Austin, Texas, 78705, United States

  • CenExel

    Hollywood, Florida, 33024, United States

  • DM Clinical Research- Texas Center for Drug Development

    Houston, Texas, 77081, United States

  • Johnson County Clinical Trials

    Lenexa, Kansas, 66219, United States

  • Meridian Clinical Research

    Savannah, Georgia, 31406, United States

  • Meridian Clinical Research

    Sioux City, Iowa, 51106, United States

  • Meridian Clinical Research

    Lincoln, Nebraska, 68510, United States

  • Tekton Research, Inc

    Austin, Texas, 78745, United States

Conditions

Explore the condition pages connected to this study.